Home / Business and Economy / GLP-1 Drugs Reshape Global Markets
GLP-1 Drugs Reshape Global Markets
28 Oct
Summary
- GLP-1 drug users are creating demand for new high-protein snack markets.
- The popularity of GLP-1 drugs is impacting the pub and beer sales industry.
- Rapid weight loss from GLP-1s is boosting the cosmetic and alteration businesses.
Globally, obesity affects one in eight individuals, leading many to seek solutions like GLP-1 drugs, known by brand names such as Ozempic and Wegovy. In the US alone, approximately 10 million adults used these drugs last year, with projections indicating over 30 million users by 2030. The market for obesity drugs is estimated to reach $150 billion by the same year.
These GLP-1 drugs are creating unforeseen market impacts. Users tend to be more calorie-conscious, boosting the demand for fortified, high-protein snacks and the supplements market. Conversely, businesses like pubs are warning of potential dips in beer sales as appetite suppression and nausea affect consumption habits.
The effects extend to wardrobes and beauty. The alteration business, catering to size changes, is thriving. Furthermore, the surge in rapid weight loss has spurred demand for cosmetic procedures like injectable fillers and collagen treatments to address "Ozempic face." New scents, inspired by food cravings, are also emerging as a compensatory market trend.
